Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Diego, California 92122


Purpose:

The purpose of this study is to evaluate the safety of long-term treatment with HZT-501.


Study summary:

Subject who have completed the 24-week Treatment Period of Horizon Protocol HZ-CA-301 or HZ-CA-303 without developing an upper gastrointestinal ulcer and who are expected to continue to require daily administration of an NSAID for the next 6 months will receive treatment with the same study medication received while participating in HZ-CA-301 or HZ-CA-303.


Criteria:

Inclusion Criteria: - Expected to continue to require daily administration of an NSAID for at least the coming 6 months. - Subject completed the 24-week Treatment period of either Horizon Protocol HZ-CA-301 or HZ-CA-303 Exclusion Criteria: - Subject didn't meet all of the Inclusion and Exclusion Criteria for Horizon Protocol HZ-CA-301 or HZ-CA-303 - Subject developed or experienced any of the following while on either HZ-CA-301 or HZ-CA-303 - Malignant Disease of the gastrointestinal tract - Erosive esophagitis - Clinically significant cardiac, renal or hepatic disease - Uncontrolled diabetes - Positive pregnancy test on Study Day 0 - Please note that there are other additional criteria. The study center will determine if you meet all of the criteria.


NCT ID:

NCT00613106


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

San Diego, California 92122
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.